GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | 8/7/2026 4:55:17 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Rev: $1,510,579 +19.0% | Assets $7,619,279 | EPS -$0.64 | |
| bioAffinity Technologies, Inc. (BIAF) | 8/7/2026 8:31:52 AM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $1,510,579 +19.0% | Assets $7,619,279 | EPS -$0.64 | Export Earnings Model | |
| bioAffinity Technologies, Inc. (BIAF) | 5/11/2026 6:15:38 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Rev: $1,351,527 -27.1% | Assets $7,945,252 | EPS -$0.81 | |
| bioAffinity Technologies, Inc. (BIAF) | 5/8/2026 8:31:59 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $1,351,527 -27.1% | Assets $7,945,252 | EPS -$0.81 | Export Earnings Model | |
| bioAffinity Technologies, Inc. (BIAF) | 3/16/2026 5:16:31 PM | View | Proxy | SEC | Y 2025 | ||||||
| bioAffinity Technologies, Inc. (BIAF) | 3/16/2026 6:15:19 AM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Rev: $6,161,959 -34.2% | Assets $10,960,772 | EPS -$8.66 | |
| bioAffinity Technologies, Inc. (BIAF) | 3/13/2026 8:31:22 AM | View | Financials | Earnings | SEC | Y 2025 | Rev $1,592,813 -27.8% | Assets $10,960,772 | EPS -$1.11 | Export Earnings Model | |
| bioAffinity Technologies, Inc. (BIAF) | 11/14/2025 4:12:34 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Rev: $1,446,066 -38.5% | Assets $11,546,369 | EPS -$4.74 | |
| bioAffinity Technologies, Inc. (BIAF) | 11/14/2025 8:31:48 AM | View | Financials | Earnings | SEC | 3Q 2025 | Rev $1,446,066 -38.5% | Assets $11,546,369 | EPS -$4.74 | Export Earnings Model | |
| bioAffinity Technologies, Inc. (BIAF) | 11/7/2025 4:15:52 PM | View | Proxy | SEC | Y 2024 | ||||||
| bioAffinity Technologies, Inc. (BIAF) | 8/14/2025 5:13:44 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Rev: $1,269,483 -47.1% | Assets $4,751,075 | EPS -$0.17 | |
| bioAffinity Technologies, Inc. (BIAF) | 8/14/2025 4:26:28 PM | View | Financials | Earnings | SEC | 2Q 2025 | Rev $1,269,483 -47.1% | Assets $4,751,075 | EPS -$0.17 | Export Earnings Model | |
| bioAffinity Technologies, Inc. (BIAF) | 6/2/2025 5:29:41 PM | View | Proxy | SEC | Y 2024 | ||||||
| bioAffinity Technologies, Inc. (BIAF) | 5/15/2025 3:43:07 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Rev: $1,853,597 -23.0% | Assets $5,547,283 | EPS -$0.16 | |
| bioAffinity Technologies, Inc. (BIAF) | 5/15/2025 9:35:07 AM | View | Financials | Earnings | SEC | 1Q 2025 | Rev $1,853,597 -23.0% | Assets $5,547,283 | EPS -$0.16 | Export Earnings Model | |
| bioAffinity Technologies, Inc. (BIAF) | 4/29/2025 5:43:56 PM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 12/31/2024 | Rev: $9,362,022 +269.7% | Assets $6,513,667 | EPS -$0.75 | |
| bioAffinity Technologies, Inc. (BIAF) | 3/31/2025 5:23:38 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Rev: $9,362,022 +269.7% | Assets $6,513,667 | EPS -$0.75 | |
| bioAffinity Technologies, Inc. (BIAF) | 3/31/2025 9:31:44 AM | View | Financials | Earnings | SEC | Y 2024 | Rev $2,207,593 -0.3% | Assets $6,513,667 | EPS -$0.21 | Export Earnings Model | |
| bioAffinity Technologies, Inc. (BIAF) | 11/22/2024 4:28:43 PM | View | Proxy | SEC | Y 2023 | ||||||
| bioAffinity Technologies, Inc. (BIAF) | 11/14/2024 4:51:20 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Rev: $2,350,386 +687.4% | Assets $6,552,014 | EPS -$0.16 | |
| bioAffinity Technologies, Inc. (BIAF) | 11/14/2024 9:30:53 AM | View | Financials | Earnings | SEC | 3Q 2024 | Rev $2,350,386 +687.4% | Assets $6,552,014 | EPS -$0.16 | Export Earnings Model | |
| bioAffinity Technologies, Inc. (BIAF) | 9/5/2024 4:39:28 PM | View | Proxy | SEC | Y 2023 | ||||||
| bioAffinity Technologies, Inc. (BIAF) | 8/14/2024 9:48:09 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Rev: $2,397,652 +12,047.4% | Assets $6,656,448 | EPS -$0.19 | |
| bioAffinity Technologies, Inc. (BIAF) | 8/14/2024 9:27:42 AM | View | Financials | Earnings | WIRE | 2Q 2024 | Rev $2,397,652 +12,047.4% | Assets $6,656,448 | EPS -$0.19 | Export Earnings Model | |
| bioAffinity Technologies, Inc. (BIAF) | 7/9/2024 4:31:57 PM | View | Financials | Earnings (Prelim) | SEC | 2Q 2024 | Export Earnings Model | ||||
| bioAffinity Technologies, Inc. (BIAF) | 5/16/2024 6:01:58 AM | View | Financials | Earnings | SEC | 1Q 2024 | Rev $2,406,391 +261,180.2% | Assets $8,049,266 | EPS -$0.20 | Export Earnings Model | |
| bioAffinity Technologies, Inc. (BIAF) | 5/15/2024 11:06:17 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Rev: $2,406,391 +261,180.2% | Assets $8,049,266 | EPS -$0.20 | |
| bioAffinity Technologies, Inc. (BIAF) | 4/15/2024 6:30:59 AM | View | Proxy | SEC | Y 2023 | ||||||
| bioAffinity Technologies, Inc. (BIAF) | 4/1/2024 4:20:54 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Rev: $2,532,499 +52,627.4% | Assets $8,221,552 | EPS -$0.91 | |
| bioAffinity Technologies, Inc. (BIAF) | 4/1/2024 4:03:19 PM | View | Financials | Earnings | SEC | Y 2023 | Rev $2,213,356 +94,246.0% | Assets $8,221,552 | EPS -$0.26 | Export Earnings Model | |
| bioAffinity Technologies, Inc. (BIAF) | 3/5/2024 5:27:33 PM | View | Financials | Earnings (Prelim) | SEC | Y 2023 | Export Earnings Model | ||||
| bioAffinity Technologies, Inc. (BIAF) | 11/15/2023 5:08:06 PM | View | Financials | Earnings | SEC | 3Q 2023 | Rev $298,484 +25,855.1% | Assets $10,189,464 | EPS -$0.26 | Export Earnings Model | |
| bioAffinity Technologies, Inc. (BIAF) | 11/14/2023 3:29:18 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Rev: $298,484 +25,855.1% | Assets $10,189,464 | EPS -$0.26 | |
| bioAffinity Technologies, Inc. (BIAF) | 8/14/2023 4:37:01 PM | View | Financials | Earnings | SEC | 2Q 2023 | Rev $19,738 | Assets $8,873,499 | EPS -$0.20 | Export Earnings Model | |
| bioAffinity Technologies, Inc. (BIAF) | 8/14/2023 4:28:44 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | ||||
| bioAffinity Technologies, Inc. (BIAF) | 5/15/2023 12:32:19 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | ||||
| bioAffinity Technologies, Inc. (BIAF) | 5/15/2023 12:24:34 PM | View | Financials | Earnings | SEC | 1Q 2023 | Rev $921 | Assets $10,464,569 | Export Earnings Model | ||
| bioAffinity Technologies, Inc. (BIAF) | 5/1/2023 2:57:15 PM | View | Proxy | SEC | Y 2022 | ||||||
| bioAffinity Technologies, Inc. (BIAF) | 4/3/2023 6:03:52 AM | View | Financials | Earnings | SEC | Y 2022 | Rev $2,346 | Assets $12,182,125 | Export Earnings Model | ||
| bioAffinity Technologies, Inc. (BIAF) | 3/31/2023 3:52:09 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Rev: $4,803 | Assets $12,182,125 | ||
| bioAffinity Technologies, Inc. (BIAF) | 11/14/2022 5:25:10 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 |